These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1079108)

  • 1. Structural and functional relationships of human antithrombin III and alpha-antitrypsin.
    Borsodi AD; Bradshaw RA; Rughani IK; Bruce RM
    Adv Exp Med Biol; 1975; 52():249-53. PubMed ID: 1079108
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of antithrombin III, alpha 2 macroglobulin and alpha 1 antitrypsin in progressive antithrombin activity of human plasma.
    Lebreton de Vonne T; Mouray H
    Int J Biochem; 1980; 12(3):479-84. PubMed ID: 6158467
    [No Abstract]   [Full Text] [Related]  

  • 3. The inhibition of activated factor XII (Hageman factor) by antithrombin III: the effect of other plasma proteinase inhibitors.
    Chan JY; Burrowes CE; Habal FM; Movat HZ
    Biochem Biophys Res Commun; 1977 Jan; 74(1):150-8. PubMed ID: 65173
    [No Abstract]   [Full Text] [Related]  

  • 4. Isolation of antithrombin III from normal and alpha1-antitrypsin-deficient human plasma.
    Borsodi AD; Bradshaw RA
    Thromb Haemost; 1977 Aug; 38(2):475-85. PubMed ID: 304258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of antithrombin III and alpha-1-antitrypsin by the perfused rat liver.
    Koj A; Regoeczi E; Toews CJ; Leveille R; Gauldie J
    Biochim Biophys Acta; 1978 Apr; 539(4):496-504. PubMed ID: 305791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of thrombin activity by antithrombin and heparin.
    Olson ST; Björk I
    Semin Thromb Hemost; 1994; 20(4):373-409. PubMed ID: 7899869
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity of thrombin and plasmin to heparin and antithrombin III.
    Bauer PI; Breuer Z; Machovich R; Büki KG; Horváth I
    Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):155-61. PubMed ID: 2944348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
    Joist JH; Cowan JF; Khan M
    J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial thrombosis due to antithrombin III deficiency in a Greek family.
    Stathakis NE; Papayannis AG; Antonopoulos M; Gardikas C
    Acta Haematol; 1977; 57(1):47-54. PubMed ID: 65891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-1-antitrypsin and its relevance to human disease.
    Luft FC
    J Mol Med (Berl); 1999 Apr; 77(4):359-60. PubMed ID: 10353439
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombin deficiency in special clinical syndromes--Part I: panel discussion.
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):37-41. PubMed ID: 8821208
    [No Abstract]   [Full Text] [Related]  

  • 12. The antithrombin activity of alpha-1-protease inhibitor: the antitrypsin activity of antithrombin III.
    Learned LA; Bloom JW; Hunter MJ
    Thromb Res; 1976 Jan; 8(1):99-109. PubMed ID: 1082656
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of a new heparin-dependent inhibitor of thrombin in human plasma.
    Tollefsen DM; Blank MK
    J Clin Invest; 1981 Sep; 68(3):589-96. PubMed ID: 6168653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of antithrombin in disorders of hemostasis].
    Róka L; Bleyl H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(6):707-18. PubMed ID: 75140
    [No Abstract]   [Full Text] [Related]  

  • 15. Introduction of a mutation in the shutter region of antithrombin (Phe77 --> Leu) increases affinity for heparin and decreases thermal stability.
    Quinsey NS; Fitton HL; Coughlin P; Whisstock JC; Dafforn TR; Carrell RW; Bottomley SP; Pike RN
    Biochemistry; 2003 Sep; 42(34):10169-73. PubMed ID: 12939144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-1-antitrypsin deficiency and liver disease.
    Propst T; Propst A; Dietze O; Judmaier G; Braunsteiner H; Vogel W
    Dig Dis; 1994; 12(3):139-49. PubMed ID: 7988061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the structural basis of alpha 1-antitrypsin deficiency.
    Lomas DA
    QJM; 1996 Nov; 89(11):807-12. PubMed ID: 8977959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 30-year perspective on alpha 1-antitrypsin deficiency.
    Eriksson S
    Chest; 1996 Dec; 110(6 Suppl):237S-242S. PubMed ID: 8989157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiological anticoagulants. Current data on the composition, function and clinical value].
    Barkagan ZS; Bishevskii KM
    Lab Delo; 1978; (10):579-87. PubMed ID: 81906
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alpha 1-antitrypsin; new perspectives].
    Feldmann G
    Gastroenterol Clin Biol; 1984; 8(8-9):667-75. PubMed ID: 6386591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.